You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Eye conditions

Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion

  • Technology appraisal guidance
  • Reference number: TA305
  • Published:  26 February 2014
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Macular oedema (central retinal vein occlusion) - aflibercept solution for injection: final appraisal determination document

Macular oedema (central retinal vein occlusion) - aflibercept solution for injection: final appraisal determination document Macular oedema (central retinal vein occlusion) - aflibercept solution for injection: final appraisal determination document
31 December 2013
(364.44 Kb 46 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 20 December 2013

Back to top